Synexus Clinical Research US, Inc.
Murray, Utah, United States
Doctor in Murray, Utah
5251 S Green St #300, Murray, UT 84123
About Synexus Clinical Research US, Inc.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Allergan
3
Eli Lilly and Company
3
Janssen Vaccines & Prevention B.V.
3
Clinical Trials at Synexus Clinical Research US, Inc.
During the past decade, Synexus Clinical Research US, Inc. conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on
average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 7 clinical trials were completed. i.e. 140%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01
2017-09-29
2020-07-08
Terminated
336
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
2018-02-01
2020-11-05
Terminated
450
12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine
2018-12-14
2020-06-19
Completed
910
A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older
2019-08-01
2024-05-16
Active, not recruiting
5,815
Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Osteoarthritis
2020-07-01
2021-08-26
Completed
117
Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain
2020-07-15
2021-11-11
Completed
125
A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants
2020-09-07
2023-03-31
Active, not recruiting
44,325
Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Chronic Low Back Pain
2020-08-25
2021-10-04
Completed
149
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Synexus Clinical Research US, Inc.
According to Clinical.Site data, the most researched conditions in "Synexus Clinical Research US, Inc." are
"Diabetes Mellitus" (2 trials), "Gastroparesis" (2 trials), "Respiratory Syncytial Viruses" (2 trials), "Chronic Low-back Pain" (1 trials) and "Diabetic Peripheral Neuropathic Pain" (1 trials). Many other conditions were trialed in "Synexus Clinical Research US, Inc." in a lesser frequency.
Clinical Trials Intervention Types at Synexus Clinical Research US, Inc.
Most popular intervention types in "Synexus Clinical Research US, Inc." are "Drug" (6 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "LY3016859" (3 trials), "Relamorelin" (2 trials), "Ad26.COV2.S" (1 trials) and "Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Synexus Clinical Research US, Inc.
The vast majority of trials in "Synexus Clinical Research US, Inc." are
9 trials for "All" genders.
Clinical Trials Status at Synexus Clinical Research US, Inc.
Currently, there are NaN active trials in "Synexus Clinical Research US, Inc.".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Synexus Clinical Research US, Inc.,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Synexus Clinical Research US, Inc., 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".